Form 4 for VERA Vera Therapeutics, Inc.
Accepted 2025-12-15 00:00:00 ET · period of report 2025-12-11 · accession 0001193125-25-319649 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-15 | 2025-12-11 | VERA | ENRIGHT PATRICK G | Dir | P - Purchase | $42.50 | +5,882 | 5,882 | New | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-12-11 | P | A | 5,882 | $42.50 | 5,882 | D | — | — |